According to UC Irvine researchers, defects in cell-surface sugars may advance short-term inflammation and long-term neurodegeneration in the central nervous systems of multiple sclerosis (MS) patients.
These findings, published online in the Journal of Biological Chemistry, imply that oral therapy may be possible through a dietary supplement resembling glucosamine, an over-the-counter product associated with arthritis relief.
Currently, there is no known cure for multiple sclerosis, a neurodegenerative disease. There are two stages to the disease, beginning with inflammation and demyelination
Filed Under: News